+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Exosome Diagnostics & Therapeutics Market by Product (Instruments, Reagents and Kits, Software and Services), Technology (Filtration, Immune Affinity Capture, Microfluidics), Source, Application, End User - Global Forecast 2025-2030- Product Image
Exosome Diagnostics & Therapeutics Market by Product (Instruments, Reagents and Kits, Software and Services), Technology (Filtration, Immune Affinity Capture, Microfluidics), Source, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Exosome Diagnostics & Therapeutics Market by Product (Instruments, Reagents and Kits, Software and Services), Technology (Filtration, Immune Affinity Capture, Microfluidics), Source, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013608
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Exosome Diagnostics & Therapeutics Market stands at the forefront of precision medicine, offering decision-makers a dynamic landscape shaped by rapid clinical and technological advancements. As healthcare shifts toward non-invasive, targeted interventions, exosome-based solutions are influencing how diseases are detected and treated, redefining standards across global healthcare systems.

Market Snapshot: Exosome Diagnostics & Therapeutics Sector at a Glance

The Exosome Diagnostics & Therapeutics Market grew from USD 1.18 billion in 2024 to USD 1.39 billion in 2025. It is expected to continue growing at a CAGR of 18.33%, reaching USD 3.24 billion by 2030. This robust expansion is driven by growing adoption of exosome-derived biomarkers, therapeutic platforms, and an expanding ecosystem of diagnostic and pharmaceutical industry partnerships. Trends include heightened demand for early disease detection, the evolution of precision drug delivery systems, and integration of sophisticated analytics into exosome workflows. Regulatory clarity and regional investments are further fueling competitive momentum and collaborative innovation.

Scope & Segmentation of the Exosome Diagnostics & Therapeutics Market

  • Product: Instruments, Reagents and Kits, Software and Services, including Consulting Services and Data Analysis capabilities
  • Technology: Filtration, Immune Affinity Capture, Microfluidics, Polymer Precipitation, and Ultracentrifugation
  • Source: Exosomes isolated from Breast Milk, Cerebrospinal Fluid, Saliva, Serum & Plasma, and Urine
  • Application: Cancer (with a focus on Breast, Colorectal, Lung, and Prostate Cancers), Cardiovascular Diseases, Infectious Diseases, Neurodegenerative Diseases, Prenatal Diagnosis, and Therapeutic Applications such as Drug Delivery and Gene Therapy
  • End User: Academic Institutes, Diagnostic Laboratories, Hospitals, Pharmaceutical and Biotechnology Companies, Research Laboratories, and Specialized Clinics
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Companies Profiled: Over twenty leading organizations including Bio-Techne Corporation, Lonza Group AG, Capricor Therapeutics, ReNeuron Group, Aethlon Medical, Direct Biologics, and System Biosciences

Key Takeaways for Senior Decision-Makers

  • Breakthrough innovations have enhanced exosome isolation and characterization, supporting more reliable non-invasive diagnostics in high-demand fields such as oncology and neurology.
  • Strategic partnerships between instrumentation suppliers, reagent developers, and biopharma companies are streamlining the transition from research to clinical practice, reducing time-to-market for new assays and therapeutics.
  • Integration of artificial intelligence and advanced data analytics into exosome analysis is accelerating biomarker discovery and optimizing individualized treatment pathways.
  • Diverse biofluid sources are opening possibilities for early disease detection and longitudinal patient monitoring across a range of applications.
  • Growing practice of cross-disciplinary consortia and real-world evidence generation enhances clinical validation, supporting broader adoption and market penetration.
  • Investments in domestic manufacturing and agile procurement models are mitigating supply chain constraints and increasing long-term operational resilience.

Tariff Impact on Exosome Diagnostics & Therapeutics Supply Chains

Recent US tariff measures have introduced new cost and operational complexities for companies dependent on imported components and reagents. To counteract financial pressures, organizations are diversifying vendor partnerships, increasing domestic sourcing, and renegotiating supply contracts. These strategic moves are fostering resilient procurement practices, supporting continued R&D momentum, and aligning with global trends toward localized biomanufacturing capacity.

Methodology & Data Sources

This report employs a hybrid methodology using both primary interviews with industry leaders and comprehensive secondary research. Peer-reviewed literature, regulatory updates, patent filings, and industry white papers were triangulated through structured analyses. Subject matter experts performed iterative validation to ensure accuracy and practical relevance.

Why This Report Matters: Strategic Value for Decision-Makers

  • Enables targeted investment and partnership strategies with a clear view of the exosome diagnostics and therapeutics landscape
  • Supports regulatory, operational, and R&D planning by providing actionable insights into current trends, technological advances, and supply chain risks
  • Informs segmentation strategies and resource allocation by spotlighting priority applications, end users, and geographic growth pockets

Conclusion

Exosome diagnostics and therapeutics are shaping new standards for precision medicine, driven by transformative technologies and international collaborations. Stakeholders leveraging strategic partnerships, agile operations, and innovative applications will capture emerging opportunities as this market continues to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of standardized isolation and characterization protocols to ensure reproducibility in clinical exosome applications
5.2. Advancements in exosome-based liquid biopsy assays for early detection of multiple cancer types
5.3. Strategic partnerships between biotech firms and academic institutions to accelerate exosome therapeutic pipelines
5.4. Emergence of synthetic exosome mimetics engineered for targeted drug delivery and enhanced stability in vivo
5.5. Integration of artificial intelligence and machine learning to enhance exosomal biomarker discovery and analysis workflows
5.6. Implementation of emerging regulatory guidelines and quality standards for clinical grade exosome manufacturing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Exosome Diagnostics & Therapeutics Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Reagents and Kits
8.4. Software and Services
8.4.1. Consulting Services
8.4.2. Data Analysis
9. Exosome Diagnostics & Therapeutics Market, by Technology
9.1. Introduction
9.2. Filtration
9.3. Immune Affinity Capture
9.4. Microfluidics
9.5. Polymer Precipitation
9.6. Ultracentrifugation
10. Exosome Diagnostics & Therapeutics Market, by Source
10.1. Introduction
10.2. Breast Milk
10.3. Cerebrospinal Fluid
10.4. Saliva
10.5. Serum & Plasma
10.6. Urine
11. Exosome Diagnostics & Therapeutics Market, by Application
11.1. Introduction
11.2. Cancer
11.2.1. Breast Cancer
11.2.2. Colorectal Cancer
11.2.3. Lung Cancer
11.2.4. Prostate Cancer
11.3. Cardiovascular Diseases
11.4. Infectious Diseases
11.5. Neurodegenerative Diseases
11.6. Prenatal Diagnosis
11.7. Therapeutic Applications
11.7.1. Drug Delivery
11.7.2. Gene Therapy
12. Exosome Diagnostics & Therapeutics Market, by End User
12.1. Introduction
12.2. Academic Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Pharmaceutical and Biotechnologies Companies
12.6. Research Laboratories,
12.7. Specialized Clinics
13. Americas Exosome Diagnostics & Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Exosome Diagnostics & Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Exosome Diagnostics & Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AEGLE Therapeutics
16.3.2. Aethlon Medical Inc.
16.3.3. AMS Biotechnology
16.3.4. Bio-Techne Corporation
16.3.5. Capital Biosciences, Inc.
16.3.6. Capricor Therapeutics, Inc.
16.3.7. Celularity Inc.
16.3.8. Direct Biologics LLC
16.3.9. Evox Therapeutics Limited
16.3.10. ExoCoBio Inc.
16.3.11. EXOGENUS THERAPEUTICS, S.A.
16.3.12. Exosome biotech company
16.3.13. ILIAS Biologics Inc.
16.3.14. KIMERA LABS
16.3.15. Lonza Group AG
16.3.16. Mercy Bioanalytics
16.3.17. NanoFCM Co., Ltd
16.3.18. NanoSomiX, Inc.
16.3.19. NeuroSense Therapeutics Ltd.
16.3.20. Promega Corporation
16.3.21. PureTech Health plc
16.3.22. ReNeuron Group plc
16.3.23. RION
16.3.24. Sienna Cancer Diagnostics Ltd
16.3.25. System Biosciences, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNE AFFINITY CAPTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IMMUNE AFFINITY CAPTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMER PRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMER PRECIPITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ULTRACENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ULTRACENTRIFUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST MILK, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST MILK, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRENATAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRENATAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGIES COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGIES COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES,, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES,, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 130. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 131. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 134. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 135. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 138. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 139. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 140. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 141. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 144. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 145. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 155. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 228. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 229. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 236. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 238. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 239. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 244. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 245. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 249. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 252. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 253. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FRANCE EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 276. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 277. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 280. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 281. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2024 (USD MILLION)
TABLE 284. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CANCER, 2025-2030 (USD MILLION)
TABLE 285. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 286. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 287. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. ITALY EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. SPAIN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. SPAIN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 292. SPAIN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 293. SPAIN EXOSOME DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Exosome Diagnostics & Therapeutics market report include:
  • AEGLE Therapeutics
  • Aethlon Medical Inc.
  • AMS Biotechnology
  • Bio-Techne Corporation
  • Capital Biosciences, Inc.
  • Capricor Therapeutics, Inc.
  • Celularity Inc.
  • Direct Biologics LLC
  • Evox Therapeutics Limited
  • ExoCoBio Inc.
  • EXOGENUS THERAPEUTICS, S.A.
  • Exosome biotech company
  • ILIAS Biologics Inc.
  • KIMERA LABS
  • Lonza Group AG
  • Mercy Bioanalytics
  • NanoFCM Co., Ltd
  • NanoSomiX, Inc.
  • NeuroSense Therapeutics Ltd.
  • Promega Corporation
  • PureTech Health plc
  • ReNeuron Group plc
  • RION
  • Sienna Cancer Diagnostics Ltd
  • System Biosciences, LLC

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.24 Billion
Compound Annual Growth Rate18.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Medicinal Exosomes Market by Exosome Source (Adult Tissue Derived, Induced Pluripotent Stem Cell, Mesenchymal Stem Cell), Therapeutic Application (Cosmetics, Diagnostics, Drug Delivery), Product Type, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Medicinal Exosomes Market by Exosome Source (Adult Tissue Derived, Induced Pluripotent Stem Cell, Mesenchymal Stem Cell), Therapeutic Application (Cosmetics, Diagnostics, Drug Delivery), Product Type, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Exosome Research Market by Product Type (Instruments, Reagents, Services), Method of Isolation (Immunoaffinity Capture, Microfluidics-based Isolation, Precipitation), Indication, Applications, End User - Global Forecast 2025-2030 - Product Image

Exosome Research Market by Product Type (Instruments, Reagents, Services), Method of Isolation (Immunoaffinity Capture, Microfluidics-based Isolation, Precipitation), Indication, Applications, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030 - Product Image

Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030

  • Report
  • 325 Pages
  • Global
From
Exosomes - Global Strategic Business Report - Product Image

Exosomes - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Exosome Diagnostic and Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Exosome Diagnostic and Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.